Bigbear Pharmaceutical·Medication Guide

• FDA Approves Sotorasib in Combination with Panitumumab for the Treatment of Metastatic Colorectal Cancer with KRAS G12C Mutation

  On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration (FDA) has approved Lumakras (sotorasib) in combination with Vectibix (···【Read More】

  Update: 2026-04-27Source: Haiou HealthViews: 73

• Sotorasib: Detailed Product Information — Indications, Dosage and Administration, and Side Effects

  Sotorasib is an oral targeted cancer therapy drug that received U.S. FDA approval in May 2021 (marketed under the brand name Lumakras). It is indicate···【Read More】

  Update: 2026-04-27Source: Haiou HealthViews: 74

• XPO1 Inhibitor Selinexor Overview

  Selinexor is an XPO-1 inhibitor clinically used to treat multiple myeloma and diffuse large B-cell lymphoma. It has shown good efficacy, improving obj···【Read More】

  Update: 2026-04-24Source: Haiou HealthViews: 78

• Does thrombocytopenia require discontinuation of celinoxetine treatment?

  Thrombocytopenia is a common adverse reaction during celinoxetine treatment. Whether or not to discontinue the medication depends primarily on its sev···【Read More】

  Update: 2026-04-23Source: Haiou HealthViews: 85

• Are there suitable ways to purchase genuine Xpovio (Selinexor)?

  Xpovio (Selinexor) is a medication used to treat multiple myeloma in adults. Genuine Xpovio can be purchased in various safe and reliable ways, and pa···【Read More】

  Update: 2026-04-22Source: Haiou HealthViews: 85

• Where is a reliable place to buy selinexor?

  Where is a reliable place to buy selinexor?When purchasing selinexor, patients should choose reputable and legitimate channels, such as hospital pharm···【Read More】

  Update: 2026-04-22Source: Haiou HealthViews: 87

• Proper Channels for Purchasing Selinexor

  Generic versions of Selinexor offer patients a more affordable treatment option; however, the channels used for purchasing them must be chosen with ca···【Read More】

  Update: 2026-04-20Source: Haiou HealthViews: 88

• How to Alleviate the Side Effects of Selinexor

  Selinexor is a novel targeted anticancer drug that has shown significant efficacy in treating multiple myeloma and diffuse large B-cell lymphoma, but ···【Read More】

  Update: 2026-04-17Source: Haiou HealthViews: 95

• Side Effects and Precautions of Celinixol

  selinexor is a drug used to treat multiple myeloma and diffuse large B-cell lymphoma. It works by inhibiting the XPO1 target. While it has shown signi···【Read More】

  Update: 2026-04-16Source: Haiou HealthViews: 93

• Xpovio (selinexor) Receives Second Oncology Approval: Large B-Cell Lymphoma (DLBCL)

  Karyopharm Therapeutics, a partner of Antengene, recently announced that the U.S. Food and Drug Administration (FDA) has approved Xpovio (selinexor) f···【Read More】

  Update: 2026-04-15Source: Haiou HealthViews: 99

• Xpovio (selinexor) Receives FDA Approval for Third Indication: Treatment of Multiple Myeloma in Patients Receiving at Least One Prior Therapy

  Karyopharm Therapeutics recently announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental New Drug Application (sNDA) ···【Read More】

  Update: 2026-04-15Source: Haiou HealthViews: 100

• Xpovio (selinexor), a novel oral drug for multiple myeloma, is nearing EU approval and is under review in China!

  Karyopharm Therapeutics recently announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has is···【Read More】

  Update: 2026-04-15Source: Haiou HealthViews: 99

• Nexpovio (selinexor) Approved in the EU, Marketing Authorization Application Accepted by China's National Medical Products Administration

  Karyopharm Therapeutics recently announced that the European Commission (EC) has conditionally approved Nexpovio (selinexor), in combination with dexa···【Read More】

  Update: 2026-04-15Source: Haiou HealthViews: 103

• The European Commission has granted full marketing authorization to selinexor (Nexpovio) in combination therapy

  The European Commission has granted full marketing authorization to selinexor (Nexpovio) in combination with once-weekly bortezomib (Velcade) and low-···【Read More】

  Update: 2026-04-15Source: Haiou HealthViews: 105

• What other medications may interact with ruxolitinib?

  Be sure to inform your healthcare provider about all medications you are using, including prescription drugs, over-the-counter products, vitamins, and···【Read More】

  Update: 2026-04-10Source: Haiou HealthViews: 100